Jason Haas - Chief Financial Officer at Syros Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
SYRS on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Jason Haas since 7/14/2023

Holdings reported by Jason Haas for Syros Pharmaceuticals, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 26.7 K $137 K $5.12 Mar 31, 2024 Direct Common Stock
Common Stock 24.6 K $126 K $5.12 Apr 1, 2024 Direct

Transactions reported by Jason Haas for Syros Pharmaceuticals, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership